Neumüller M, Karlström A R, Källander C F, Gronowitz J S
Research Unit of Replication Enzymology, Uppsala University, Sweden.
Biotechnol Appl Biochem. 1990 Feb;12(1):34-56.
A one-step procedure which uses enzymes in a crude extract of herpes simplex virus (HSV) type 1-infected cells to synthesize 5-[125I]iodo-2'-deoxyuridine triphosphate [( 125I]dUTP) from [125I]dU is described. The design of a one-step procedure for the purification of the product is also presented. The recovery of [125I]dUTP from [125I]dU varied between 50 and 75%, the radiochemical purity of the product was greater than 90%, and both synthesis and purification were completed within 8 h. The sensitivity and specificity of [125I]dUTP as a substrate for both DNA-dependent DNA polymerase (DNAp) and RNA-dependent DNA polymerase (reverse transcriptase, RT) were evaluated and compared to those of [3H]dTTP for the following specimens: purified cloned Klenow fragment, crude extracts of HeLa-, BHK-, and HSV-2-infected BHK cells, purified avian myeloblastosis virus RT, and purified cloned human immunodeficiency virus (HIV) RT. The [125I]dUTP was accepted as a substrate equally as well [3H]dTTP by all of the specimens at all of the concentrations tested. When the same amount of radiolabel was used, [125I]dUTP gave a sensitivity 10- to 25-fold higher than that of [3H]dTTP. The gain in sensitivity was due to the higher specific activity and a higher counting efficiency of the 125I-label compound. The use of [125I]dUTP also offered technical advantages over alternative substrates available, such as product separation without acid precipitation and exclusion of the need for scintillation cocktails. The half-life of the nucleic also gives a reasonable shelf-life for use in routine assays. Activity of less than 0.3 pg of HIV RT could be detected when the new substrate was used, and this made it possible to quantitate HIV RT antibodies (abs) in diluted serum samples without purifying the immunoglobulin. Analysis of 31 HIV-infected individuals showed that all of them had anti-HIV RT ab and that the amount of serum needed for 50% inhibition of the HIV RT activity corresponded to an amount of immunoglobulin 100-fold smaller (i.e., 0.02-31.4 micrograms) than has been previously reported. With the substrate it was also possible to detect DNAp activity in serum from healthy individuals, although a long-duration assay was required. In a long-duration assay the DNAp activity found in sera from healthy individuals was linear with respect to time, whereas the DNAp activity found in many sera from tumor patients was not. [125I]dUTP is judged to be an excellent substrate for detecting and quantifying the activity of various DNA-synthesizing enzymes and their blocking abs.
本文描述了一种一步法,该方法利用1型单纯疱疹病毒(HSV)感染细胞的粗提物中的酶,从[125I]dU合成5-[125I]碘-2'-脱氧尿苷三磷酸([125I]dUTP)。同时还介绍了一步法纯化产物的设计。从[125I]dU中回收[125I]dUTP的回收率在50%至75%之间,产物的放射化学纯度大于90%,合成和纯化均在8小时内完成。评估了[125I]dUTP作为依赖DNA的DNA聚合酶(DNAp)和依赖RNA的DNA聚合酶(逆转录酶,RT)底物的敏感性和特异性,并与[3H]dTTP对以下标本的敏感性和特异性进行了比较:纯化的克隆Klenow片段、HeLa细胞、BHK细胞和HSV-2感染的BHK细胞的粗提物、纯化的禽成髓细胞瘤病毒RT以及纯化的克隆人免疫缺陷病毒(HIV)RT。在所有测试浓度下,所有标本对[125I]dUTP作为底物的接受程度与[3H]dTTP相同。当使用相同量的放射性标记时,[125I]dUTP的敏感性比[3H]dTTP高10至25倍。敏感性的提高归因于125I标记化合物的更高比活性和更高计数效率。使用[125I]dUTP还具有优于其他可用底物的技术优势,例如无需酸沉淀即可分离产物,并且无需闪烁液。核酸的半衰期也为常规检测提供了合理的保质期。使用新底物时,可以检测到活性低于0.3 pg的HIV RT,这使得在不纯化免疫球蛋白的情况下定量稀释血清样本中的HIV RT抗体(abs)成为可能。对31名HIV感染个体的分析表明,他们都有抗HIV RT抗体,并且抑制50%HIV RT活性所需的血清量对应的免疫球蛋白量比先前报道的小100倍(即0.02至31.4微克)。使用该底物还可以检测健康个体血清中的DNAp活性,尽管需要进行长时间检测。在长时间检测中,健康个体血清中发现的DNAp活性随时间呈线性,而许多肿瘤患者血清中发现的DNAp活性则不然。[125I]dUTP被认为是检测和定量各种DNA合成酶及其阻断抗体活性的优良底物。